Vanity Citrus complements the biological portfolio of Bayer which includes Serenade, BioAct, and Flipper that were broadly adopted by European growers.
The Horizon Europe project SAGROPIA has successfully launched, marking the beginning of a promising five-year collaborative approach to research and innovation in sustainable crop protection